Drug Type Small molecule drug |
Synonyms Exentra, 엑센트라노즈연질캡슐 |
Target |
Action inhibitors, antagonists |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (09 Feb 2026), |
Regulation- |
Molecular FormulaC20H23ClN2O4 |
InChIKeyDBAKFASWICGISY-BTJKTKAUSA-N |
CAS Registry113-92-8 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Excessive tearing | Australia | 02 Jul 2026 | |
| Influenza, Human | Australia | 02 Jul 2026 | |
| Pruritus | Australia | 02 Jul 2026 | |
| Sneezing | Australia | 02 Jul 2026 | |
| Common Cold | South Korea | 09 Feb 2026 |





